|
NPDC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
3.24584803479411E-12 |
| Normal-vs-Stage3 |
1.62447832963153E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
4.288800E-01 |
| Stage1-vs-Stage3 |
8.170800E-01 |
| Stage1-vs-Stage4 |
2.734200E-02 |
| Stage2-vs-Stage3 |
5.389600E-01 |
| Stage2-vs-Stage4 |
4.143600E-01 |
| Stage3-vs-Stage4 |
6.194300E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.52910000112061E-08 |
| Normal-vs-Asian |
3.33066907387547E-16 |
| Caucasian-vs-AfricanAmerican |
5.186200E-01 |
| Caucasian-vs-Asian |
3.222400E-01 |
| AfricanAmerican-vs-Asian |
2.316400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
4.459000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
1.582740E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.592800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.827600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.105400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.981400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.659200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.059200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.810600E-01 |
| Classical-VS-Follicular |
8.041200E-01 |
| Classical-VS-Other |
9.610200E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
4.654800E-01 |
| Tall-VS-Other |
8.167600E-01 |
| Tall-VS-Normal |
1.62625468647093E-12 |
| Follicular-VS-Other |
9.757400E-01 |
| Follicular-VS-Normal |
<1E-12 |
| Other-VS-Normal |
8.119100E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62447832963153E-12 |
| Normal-vs-N1 |
1.11022302462516E-16 |
| N0-vs-N1 |
1.289230E-01 |
|
|
